Free Access
J Extra Corpor Technol
Volume 39, Number 4, December 2007
Page(s) 238 - 242
Published online 15 December 2007
  1. Edwards M. Keywords in the history of medicine: Evidence. Lancet. 2004;363:1657. [CrossRef] [PubMed] [Google Scholar]
  2. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: What it is and what it isn’t. BMJ. 1996;13:71–2. [CrossRef] [PubMed] [Google Scholar]
  3. Likosky DS. Integrating evidence-based perfusion into practices: The International Consortium for Evidence-Based Perfusion. J Extra Corpor Technol. 2006;38:297–301. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  4. Likosky DS. A primer on reviewing and synthesizing evidence. J Extra Corpor Technol. 2006;38:112–5. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  5. Shann KG, Likosky DS, Murkin JM, et al. An evidence-based review of the practice of cardiopulmonary bypass in adults: A focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J Thorac Cardiovasc Surg. 2006;132:238–49. [Google Scholar]
  6. Williams MR, D’Ambra AB, Beck JR, et al. A randomized trial of antithrombin concentrate for treatment of heparin resistance. Ann Thorac Surg. 2000;70:873–7. [CrossRef] [Google Scholar]
  7. Avidan MS, Levy JH, Scholz J, et al. A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass. Anesthesiology. 2005;102:276–84. [CrossRef] [PubMed] [Google Scholar]
  8. DeBois WJ, Liu J, Elmer B, et al. Heparin sesitivity test for patients requiring cardiopulmonary bypass. J Extra Corpor Techol. 2007;38:307–9. [Google Scholar]
  9. Lemmer JH, Despotis GJ. Antithrombin III concentrate to treat heparin resistance in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2002;123:213–7. [CrossRef] [Google Scholar]
  10. Ranucci M, Frigiola A, Menicanti L, et al. Risk factors for fatal myocardial infarction after coronary bypass graft surgery. Eur J Anaesthesiol. 2001;18:322–9. [CrossRef] [PubMed] [Google Scholar]
  11. Nicolson SC, Keeling DM, Sinclair ME, Evans RD. Heparin pre-treatment does not alter heparin requirements during cardiopulmonary bypass. Br J Anaesth. 2001;87:844–7. [CrossRef] [Google Scholar]
  12. Linden MD, Schneider M, Baker S, Erber WN. Decreased concentration of antithrombin after preoperative therapeutic heparin does not cause heparin resistance during cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2004;18:131–5. [CrossRef] [Google Scholar]
  13. Vuylsteke A, Mills RJ, Crosbie AE, Burns TK, Latimer RD. Increased pre-operative platelet counts are a possible predictor for reduced sensitivity to heparin. Br J Anaesth. 2000;85:896–8. [CrossRef] [Google Scholar]
  14. Young J, Kisker C, Doty D. Adequate anticoagulation during cardiopulmonary bypass determined by activated clotting time and the appearance of fibrin monomer. Ann Thorac Surg. 1978;23:231–40. [CrossRef] [Google Scholar]
  15. Stanworth SJ, Brunskill SJ, Hyde CJ, McClelland DBL, Murphy MF. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol. 2004;126:139–52. [CrossRef] [Google Scholar]
  16. Chan T, Hwang NC, Lim CH. A statistical analysis of factors predisposing patients to heparin resistance. Perfusion. 2006;21:99–103. [CrossRef] [PubMed] [Google Scholar]
  17. Conley JC, Plunkett PF. Antithrombin III in cardiac surgery: An outcome study. J Extra Corpor Technol. 1998;30:178–83. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  18. Staples MH, Dunton RF, Karlson KJ, Leonardi HK, Berger RL. Heparin resistance after preoperative heparin therapy or intraaortic balloon pumping. Ann Thorac Surg. 1994;57:1211–6. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.